MENU

NIPRO

News Release

These news releases are meant to provide information on NIPRO’s corporate activities and an overview of our initiatives to not only the press but also our many stakeholders, including shareholders and investors in a fair and timely manner.
The information about NIPRO products and services included in these releases are not intended for use in attracting customers or as medical advice.

August 13, 2026: Impact on the NIPRO Group from the Earthquake in Colombia (326KB)
August 4, 2026: NIPRO Introduces Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance (318KB)
Announcement of Spryte Medical, a US Affiliate of NIPRO, Completion of Subject Enrollment in the “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment (270KB)
July 30, 2026: NIPRO CORPORATION Receives FDA 510(k) Clearance for ELISIO™-HX, Introducing HDs to the United States (195KB)
July 29, 2026: Notice Concerning Expected Recording of Extraordinary Income from Sale of Investment Securities (107KB)
June 26, 2026: Notice of Personnel Changes (204KB)
Notice Concerning Changes in Subsidiary and Equity-Method Affiliate (129KB)
May 22, 2026: Notice of Personnel Changes (236KB)
April 28, 2026: Notice of Personnel Changes (182KB)
April 24, 2026: Social Finance Framework (1,302KB)
Second-Party Opinion on NIPRO's Social Finance Framework (2,673KB)
April 3, 2026: Notice of Personnel Changes (73KB)
April 1, 2026: Instruction for New Employees from President Yamazaki at Induction Ceremony 2026 (346KB)
March 25, 2026: Announcement of Investment by Development Bank of Japan Inc. in a U.S. Subsidiary of NIPRO (324KB)
March 24, 2026: Notice Concerning Change in Depreciation Method (96KB)
March 18, 2026: Announcement of Spryte Medical, a US Affiliate of NIPRO, First Participants Enrolled in the “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment (272KB)
March 11, 2026: Notice Concerning the Establishment of the Record Date for the Year-End Dividend (105KB)
March 10, 2026: Notice of Organizational Changes and Consolidation of U.S. Subsidiaries in Vascular Division (224KB)
February 26, 2026: Announcement of Expansion of Commercial Collaboration Between Gentuity LLC, a US Affiliate of NIPRO, and GE HealthCare (146KB)
February 25, 2026: Notice Regarding the Establishment of the Nomination and Compensation Committee (105KB)
February 4, 2026: Announcement of Avantec Vascular, a US Affiliate of NIPRO, Receives FDA 510 (k) clearance of Thrombectomy System (170KB)
January 5, 2026: President’s Greetings for 2026 (375KB)

© NIPRO